Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan/Chlorthalidone vs Losartan/HCTZ in Hypertension
NCT04927299Phase 3Completed
- Sponsor
- Laboratorios Silanes
- Start
- Jun 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chlorthalidone in essential hypertension, sponsored by Laboratorios Silanes. Started Jun 2022; status: completed.
02
Drugs
chlorthalidone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT04927299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04927299.